Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leramistat in Rheumatoid Arthritis
NCT05460832Phase 2Completed
- Sponsor
- Modern Biosciences
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of Leramistat in rheumatoid arthritis (RA), sponsored by Modern Biosciences. Started Aug 2022; status: completed.
02
Drugs
Leramistat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05460832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460832.